×
About 6,755 results

ALLMedicine™ Calcitonin Center

Research & Reviews  2,356 results

Hypercalcaemia in Mycobacterium kansasii pulmonary infection.
https://doi.org/10.1136/bcr-2021-245800
BMJ Case Reports; Flowers RC, Ocampo J et. al.

Dec 2nd, 2021 - A gentleman in his 60s with end-stage kidney disease status post kidney transplantation on prednisone and tacrolimus presented with generalised weakness for 7 days, associated with altered mental status. Investigations revealed pancytopenia, acute...

Diurnal changes of colonic motility and regulatory factors for colonic motility in Sunc...
https://doi.org/10.1111/nmo.14302
Neurogastroenterology and Motility : the Official Journal... Kobayashi Y, Takemi S et. al.

Dec 1st, 2021 - The aim of this study was to investigate the fundamental mechanisms of colonic motility in the house musk suncus (Suncus murinus) as an established animal model of gut motility. To measure gut motility in free-moving conscious suncus, strain gauge...

Spindle cell variant of medullary thyroid carcinoma: a clinicopathologic study of four ...
https://doi.org/10.1186/s13000-021-01152-w 10.1159/000328348 10.1002/dc.20656 10.1007/s10147-013-0588-8 10.1089/thy.2014.0335 10.1309/4DQW6RQX3C6KRX1J
Diagnostic Pathology; Wang YX, Yang SJ

Nov 29th, 2021 - Medullary thyroid carcinoma (MTC) is a malignant tumor derived from C cells. It accounts for about 10% of all thyroid malignancies. More than 14 histological variants have been described. Among them, spindle cell variant is extremely rare. Here we...

PACAP38- and VIP-induced cluster headache attacks are not associated with changes of pl...
https://doi.org/10.1177/03331024211056248
Cephalalgia : an International Journal of Headache; Pellesi L, Chaudhry BA et. al.

Nov 26th, 2021 - Pituitary adenylate cyclase-activating polypeptide-38 (PACAP38) and vasoactive intestinal polypeptide can provoke cluster headache attacks in up to half of cluster headache patients in their active phase. At present, it is unknown whether provoked...

see more →

Guidelines  3 results

European headache federation guideline on the use of monoclonal antibodies acting on th...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6734227
The Journal of Headache and Pain; Sacco S, Bendtsen L et. al.

Jan 18th, 2019 - Monoclonal antibodies acting on the calcitonin gene-related peptide or on its receptor are new drugs to prevent migraine. Four monoclonal antibodies have been developed: one targeting the calcitonin gene-related peptide receptor (erenumab) and thr...

The treatment of symptomatic osteoporotic spinal compression fractures.
https://doi.org/10.5435/00124635-201103000-00007
The Journal of the American Academy of Orthopaedic Surgeons; Esses SI, McGuire R et. al.

Mar 4th, 2011 - This clinical practice guideline is based on a series of systematic reviews of published studies on the treatment of symptomatic osteoporotic spinal compression fractures. Of 11 recommendations, one is strong; one, moderate; three, weak; and six, ...

The North American Neuroendocrine Tumor Society consensus guideline for the diagnosis a...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3419007
Pancreas Chen H, Sippel RS et. al.

Jul 29th, 2010 - Pheochromocytomas, intra-adrenal paraganglioma, and extra-adrenal sympathetic and parasympathetic paragangliomas are neuroendocrine tumors derived from adrenal chromaffin cells or similar cells in extra-adrenal sympathetic and parasympathetic para...

see more →

Drugs  22 results see all →

Clinicaltrials.gov  68 results

A Controlled Trial of Erenumab in Migraine Prevention
https://clinicaltrials.gov/ct2/show/NCT03812224

Nov 16th, 2021 - Migraine prevention is an area of a large unmet medical need, with existing therapies often having modest efficacy and poor tolerability. Calcitonin gene-related peptide (CGRP) receptor antagonism is a novel approach to migraine preventive therapy...

The Effects of Levcromakalim in Patients With Cluster Headache
https://clinicaltrials.gov/ct2/show/NCT05093582

Oct 26th, 2021 - Cluster headache is a primary headache disorder characterized by attacks of unilateral headache of short duration and severe pain intensity. There is an unmet need to understand the underlying disease mechanisms that will ultimately lead to the de...

Remote Ischemic Preconditioning in Patients Undergoing Acute Minor Abdominal Surgery
https://clinicaltrials.gov/ct2/show/NCT04156711

Sep 29th, 2021 - Remote ischemic preconditioning (RIPC) consists of cycles of forearm or leg ischemia and reperfusion by the inflation of a blood-pressure cuff over the systemic blood pressure for brief periods. The procedure is simple, safe and with no clear side...

Neuropeptides and Venous Pelvic Pain
https://clinicaltrials.gov/ct2/show/NCT03921788

Sep 21st, 2021 - The first phase of the study includes a set of 3 patient groups: the first is patients with pelvic vein dilation and blood reflux through them in combination with venous pelvic pain; the second is patients with pelvic vein dilatation without venou...

Management of Migraine Using Enerumab and Traditional Therapy at the Time of COVID-19
https://clinicaltrials.gov/ct2/show/NCT05052008

Sep 21st, 2021 - Migraine is a debilitating disorder that affects 37 million people in the United States. Recently, three new injectables calcitonin gene-related peptide (CGRP) receptor antagonists-erenumab, fremanezumab, and galcanezumab-were FDA approved for pro...

see more →

News  250 results

Atogepant Reduces Migraine Days: ADVANCE Trial Published
https://www.medscape.com/viewarticle/957192

Aug 25th, 2021 - The novel calcitonin gene-related peptide (CGRP) antagonist atogepant is safe and effective for the preventive treatment of migraine, full results from a phase 3 trial suggest. AbbVie, the company developing the oral therapy, announced topline res...

AHS Releases Updated Guidance on New Migraine Treatments
https://www.medscape.com/viewarticle/954940

Jul 16th, 2021 - An updated consensus statement from the American Headache Society (AHS) offers detailed recommendations on the use of novel acute and preventive treatments in adult patients with migraine. "Because the benefit–risk profiles of newer treatments wil...

New Migraine Treatments: Which Is Right for Your Patients?
https://www.medscape.com/viewarticle/953769

Jul 2nd, 2021 - It's an exciting time to be treating people with migraine. The past several years have seen a profusion of new migraine treatment options, and clinicians have more choices to offer patients than ever. In addition to acute and preventive therapies ...

Migraine Frequency, Severity Drop Substantially With Diet Interventions
https://www.medpagetoday.com/neurology/migraines/93375

Jun 30th, 2021 - A diet higher in two omega-3 fatty acids, eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), reduced headache frequency and intensity and lowered levels of pain-related lipids in migraine patients, a randomized controlled trial showed. Co...

Understanding the pathophysiology of medication overuse headache
https://www.mdedge.com/migraine-icymi/article/242061/understanding-pathophysiology-medication-overuse-headache
Alan M. Rapoport, MD

Jun 24th, 2021 - Last month’s column focused on medication overuse headache and pointed out an excellent review article by Sun-Edelstein and colleagues. Another fascinating topic also covered within that paper that warrants closer examination is pathogenesis.

see more →

Patient Education  3 results see all →